Product
Zifibancimig
1 clinical trial
1 indication
Indication
Age-Related Macular DegenerationClinical trial
A Three-Part, Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery From the Port Delivery in Patients With Neovascular Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2026-02-09